About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.
2018 Juristant Badge - MBHB_165
Juristat #4 Overall Rank

E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.

Contact the Docs


  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat #8 Overall Rank


« Court Report | Main | FDA Discusses Initial Considerations for Biosimilar Guidance Documents »

February 27, 2012



Thanks for putting some "reality" into this "fantasy" legislation. Why am I not surprised that this "fantasy" legislation is being supported by Waxman and his other Democratic ilk that simply believe America is the "land of entitlement" (instead of the "land of opportunity"). And giving enforcement authority for this "fantasy" legislation to the FTC who believe the only "good" patent is a "dead" patent is a smart idea, right? I truly hope this "fantasy" legislation is torched in committee. We don't need any more AIAs (aka Abominable Inane Acts).

The comments to this entry are closed.

February 2024

Sun Mon Tue Wed Thu Fri Sat
        1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29